Chronic Kidney Disease Registry Platform Study

Study identifier:D1843R00355

ClinicalTrials.gov identifier:NCT06117852

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Chronic Kidney Disease Registry Platform Study

Medical condition

Chronic Kidney Diseases

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

5000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 28 Nov 2023
Estimated Primary Completion Date: 31 Dec 2026
Estimated Study Completion Date: 31 Dec 2026

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria